Evidence map›Paper›PMID 27304068›Full record

ArticlePloS one2016

Comparison of Outcomes between Individuals with Pure and Mixed Lupus Nephritis: A Retrospective Study.

Titilayo O Ilori, Nosayaba Enofe, Anju Oommen, Jason Cobb, Jose Navarrete, Demilade A Adedinsewo, Oluwatobiloba Oshikoya, Helene Fevrier, Alton B Farris, Laura Plantinga and 1 more

Abstract readComparative Study
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Titilayo O IloriDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Nosayaba EnofeDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Anju OommenDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Jason CobbDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Jose NavarreteDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Demilade A AdedinsewoDepartment of Medicine, Morehouse School of Medicine, Atlanta, Georgia, United States of America.
Oluwatobiloba OshikoyaInstitute for Cardiovascular and Metabolic Disease, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Helene FevrierHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
Alton B FarrisDepartment of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Laura PlantingaDivision of Nephrology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Akinlolu O OjoDivision of Nephrology, University of Michigan, Ann Arbor, Michigan, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLupus nephritis (LN) is a serious organ manifestation of systemic lupus erythematosus. Histologic overlap is relatively common in the six pathologic classes (I to VI) of LN. For example, mixed proliferative LN (MPLN) often includes features of classes III & V or classes IV & V combined. We performed a comparative evaluation of renal outcomes in patients with MPLN to patients with pure proliferative LN (PPLN) against pre-specified renal outcomes, and we also identified predictor of clinical outcomes among those with PPLN and MPLN. HYPOTHESIS: Individuals with MPLN will have worse short-term renal outcomes compared to those with PPLN.

methodsWe retrospectively reviewed 278 adult LN patients (≥18 years old) identified from an Emory University Hospital registry of native renal biopsies performed between January 2000 and December 2011. The final analytic sample consisted of individuals with a diagnosis of PPLN (n = 60) and MPLN (n = 96). We analyzed differences in clinical and laboratory characteristics at baseline. We also assessed associations between LN category and renal outcomes (complete remission and time to ESRD) with logistic and Cox proportional hazards models within two years of baseline.

resultsThe study population was predominantly female (83.97%) and African American (71.8%) with a mean age of 33.4 years at baseline. Over a median follow up of 1.02 years, we did not find any statistically significant associations between MPLN and the development of ESRD or remission when compared to patients with PPLN (adjusted HR = 0.30, 95% CI = 0.07, 1.26).

conclusionThere was no association between mixed or pure histopathologic features of LN at presentation and rate of complete or partial remission but higher baseline eGFR was associated with a lower probability of complete remission among patients with lupus nephritis.

Indexed as

AdultBiopsyFemaleGlomerular Filtration RateHumansKaplan-Meier EstimateKidneyKidney Failure, ChronicLogistic ModelsLupus NephritisMaleMiddle AgedOutcome Assessment, Health CareProportional Hazards ModelsRegistriesRetrospective Studies

Identifiers

PMID27304068
PMCPMC4909281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.